Mylitrans Injection
Marketer
United Biotech Pvt Ltd
Salt Composition
Methylcobalamin (1000mcg) + Niacinamide (100mg) + Vitamin B6 (Pyridoxine) (100mg)
Overview Mylitrans Injection
Nutritain Injectable Solution is a supportive medication addressing vitamin and other nutritional insufficiencies, promoting healthy bodily growth and function. Administration must be overseen by a qualified healthcare provider; self-injection is strictly prohibited. Report any allergies to this medication to your physician. Minor injection site reactions, including redness, swelling, or pain, may occur; these typically resolve spontaneously, but persistent symptoms warrant medical attention. Disclose any pre-existing conditions or concurrent medications to your doctor.
Uses of Mylitrans Injection
Addressing Nutritional Imbalances
Major Benefits of Mylitrans Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Mylitrans Injection:
- No common side effects seen
How to use Mylitrans Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not recommended.
How Mylitrans Injection works:
Mylitrans Injection delivers a synergistic blend of methylcobalamin, niacinamide, and pyridoxine (vitamin B6), restoring essential nutrient levels within the body.
SAFETY ADVICE
AlcoholCAUTION
Use of Mylitrans Injection with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Mylitrans Injection in pregnant individuals is lacking. Seek medical advice from your physician.
Breast feedingSAFE IF PRESCRIBED
Administration of Mylitrans Injection is considered safe while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no appreciable risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Mylitrans Injection.
KidneySAFE IF PRESCRIBED
The use of Mylitrans Injection in individuals with kidney impairment appears to pose minimal risk. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Mylitrans Injection in individuals with hepatic impairment appears to pose minimal risk. Preliminary findings indicate that dosage modification may not be necessary for this population. Physician consultation is advised.
What if you forget to take Mylitrans Injection :
Should you forget a scheduled dose of Mylitrans Injection, seek advice from your physician.
Facts to Know About Mylitrans Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Essential Nutrients |
3,018 People bought this recently